West Pharmaceutical Services, Inc. WST NYSE

West Pharmaceutical Services, Inc. (WST) reported total assets of $4.27B and total liabilities of $1.09B for fiscal year 2025, resulting in total equity of $3.18B.

The company held $791.3M in cash and short-term investments. Total debt stood at $416.7M, with net debt of $-374.6M. The Debt-to-Equity (D/E) ratio was 0.13 (conservative).

Current ratio is 3.02, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.13, current ratio of 3.02 — balance sheet is strong
• MOAT (57/100) — Total assets $4.27B and equity $3.18B support the company's competitive scale
• VALUE (29/100) — Debt-to-Equity 0.13 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 66/100 with 4/7 criteria passed.

BDX

Becton, Dickinson and Company

$155.73

+0.19%

ALC

Alcon Inc.

$79.94

+0.25%

RMD

ResMed Inc.

$230.69

+0.19%

LH

Labcorp Holdings Inc.

$268.87

+1.78%

STE

STERIS plc

$224.83

-0.01%

DGX

Quest Diagnostics Incorporated

$194.16

+0.65%

ILMN

Illumina, Inc.

$130.32

+2.65%

WAT

Waters Corporation

$330.98

+1.94%